Cargando…
MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha
Aberrant expression of miR-196a has been frequently reported in different cancers including pancreatic cancer. However, its function in pancreatic cancer has not been fully elucidated. Here, we investigated the expression pattern and the biological role of miR-196a in pancreatic cancer cell lines, a...
Autores principales: | Huang, Fengting, Tang, Jian, Zhuang, Xiaohong, Zhuang, Yanyan, Cheng, Wenjie, Chen, Wenbo, Yao, Herui, Zhang, Shineng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913664/ https://www.ncbi.nlm.nih.gov/pubmed/24504166 http://dx.doi.org/10.1371/journal.pone.0087897 |
Ejemplares similares
-
LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis
por: Huang, Fengting, et al.
Publicado: (2018) -
Retraction Note to: LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis
por: Huang, Fengting, et al.
Publicado: (2022) -
CircMYOF triggers progression and facilitates glycolysis via the VEGFA/PI3K/AKT axis by absorbing miR-4739 in pancreatic ductal adenocarcinoma
por: Zheng, Dandan, et al.
Publicado: (2021) -
Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment
por: Zhuang, Yanyan, et al.
Publicado: (2023) -
METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma
por: Lu, Liting, et al.
Publicado: (2022)